top of page
Nanomedicines Alliance Session at 2nd FDA/PQRI Conference on Advancing Product Quality


In October 2015, the Nanomedicines Alliance co-led the panel session Current Challenges in the Characterization of Complex Drug Formulations Containing Nanomaterials with FDA at the 2nd FDA/PQRI Conference on Advancing Product Quality in Bethesda, MD.


View the complete conference program.

Events Sponsored by the Nanomedicines Alliance

Nanomedicines: Charting a Roadmap to Commercialization


On 6-7 March 2013, the Nanomedicines Alliance held an Industry Symposium: Charting a Road to Commercialization. A white paper on the Symposium, Nanomedicine Drug Development: A Scientific Symposium Entitled Charting a Roadmap to Commercialization, has been published in the AAPS Journal.


The Symposium addressed:


  • desigining nanomedicines


  • preclinical pharmacology


  • chemistry, manufacturing & controls


  • toxicology/ADME


  • clinical studies


2016 Global Summit on Regulatory Science: Nanotechnology Standards and Applications


In September 2016 Clarice Hutchens from the Nanomedicines Alliance presented at the Regulatory Summit on Nanotechnology Standards and Applications hosted by the National Institutes of Health and attended by global regulatory authorities.


View the agenda for the 2016 Global Summit on Regulatory Science.

2017 AAPS Annual Meeting


At the 2017 AAPS Annual Meeting Gregory Troiano, Vice President Nanomedicine Development & Manufacturing, Pfizer Inc, will present a Symposium Commercializing Nanomedicine—Industrial Perspective during a session on New Generation Nanomedicines: Scientific and Regulatory Challenges.

bottom of page